헬스케어용 ESG 시장 예측(-2034년) : ESG 구성 요소, 제공 형태, 도입 형태, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global ESG in Healthcare Market is accounted for $21.1 billion in 2026 and is expected to reach $38.0 billion by 2034 growing at a CAGR of 7.6% during the forecast period. ESG in healthcare refers to the integration of environmental, social, and governance criteria into the operations, strategy, and reporting of healthcare organizations, including hospitals, pharmaceutical companies, and medical device manufacturers. This market addresses the growing demand for sustainable healthcare practices, from reducing carbon emissions and medical waste to ensuring equitable patient access and transparent corporate governance. As regulators, investors, and patients increasingly scrutinize healthcare's broader societal impact, ESG solutions are becoming essential for risk management, compliance, and long-term value creation across the industry.

Market Dynamics:

Driver:

Rising pressure from investors and regulators for sustainable healthcare operations

Financial institutions and government bodies are increasingly requiring healthcare organizations to disclose ESG metrics, tying access to capital and reimbursement rates to sustainability performance. Major asset managers now integrate ESG scores into investment decisions, pushing hospital networks and pharmaceutical giants to adopt measurable environmental and social targets. Simultaneously, regulators in the European Union and North America are mandating greenhouse gas reporting and supply chain due diligence for human rights violations. This dual pressure creates a compelling business case for dedicated ESG solutions, as healthcare entities that fail to demonstrate progress face higher borrowing costs, regulatory penalties, and loss of institutional investor confidence.

Restraint:

High implementation costs and lack of standardized ESG metrics

Many healthcare organizations, particularly smaller clinics and regional hospitals, struggle to justify the upfront investment required for robust ESG infrastructure, including software platforms, data collection systems, and consulting engagements. The absence of universally accepted ESG reporting standards across healthcare sub-sectors further complicates adoption, as providers face confusion over which metrics to track and how to benchmark performance. Different frameworks from GRI, SASB, and TCFD create administrative burdens, while the need to integrate ESG data from legacy IT systems adds technical complexity. These financial and operational barriers slow market penetration, especially in developing regions with constrained healthcare budgets.

Opportunity:

Integration of ESG with digital health transformation initiatives

As healthcare systems worldwide accelerate digitalization through electronic health records, telemedicine, and AI-driven diagnostics, ESG considerations can be seamlessly embedded into these technology investments. Cloud-based ESG platforms can leverage existing data streams from energy management systems, procurement databases, and patient satisfaction surveys to automate reporting and identify improvement opportunities. The convergence of digital health and ESG creates cross-functional efficiencies, reducing the incremental cost of sustainability efforts. Early adopters that integrate ESG into their digital roadmaps gain competitive advantages through lower operational costs, enhanced brand reputation, and readiness for emerging regulatory requirements, opening substantial market opportunities for integrated solution providers.

Threat:

Greenwashing allegations and stakeholder skepticism in healthcare

Healthcare organizations face intense scrutiny over claims of environmental or social responsibility, given the sector's historically high resource consumption and waste generation. Exaggerated marketing about sustainable practices, such as minor reductions in plastic packaging while ignoring pharmaceutical pollution, can backfire spectacularly when exposed. Patient advocacy groups, whistleblowers, and investigative journalists are increasingly vigilant, and viral social media campaigns can rapidly damage institutional credibility. The resulting fear of reputational harm makes some healthcare leaders hesitant to publicly commit to ESG goals, slowing adoption of transparent reporting solutions and favoring cautious, incremental approaches that limit market expansion for comprehensive ESG software.

Covid-19 Impact:

The COVID-19 pandemic dramatically reshaped ESG priorities in healthcare by exposing deep vulnerabilities in supply chains, workforce resilience, and waste management protocols. Massive surges in single-use personal protective equipment and vaccine-related disposables intensified environmental concerns, while staff burnout and health inequities became front-page social issues. These revelations prompted healthcare executives to accelerate ESG investments as strategic imperatives rather than optional initiatives. Governments introduced pandemic-related funding conditional on improved environmental and social metrics. The crisis also normalized remote ESG assessments and virtual consulting, permanently reducing barriers to entry for software-based solutions and expanding the addressable market across previously hesitant healthcare segments.

The Environmental Solutions segment is expected to be the largest during the forecast period

The Environmental Solutions segment is expected to account for the largest market share during the forecast period, driven by healthcare's substantial carbon footprint and waste generation. Hospitals operate around the clock, consuming massive amounts of energy for heating, cooling, lighting, and medical equipment, while generating millions of tons of pharmaceutical, plastic, and hazardous waste annually. Regulators are imposing stricter emissions limits and waste disposal requirements, compelling healthcare providers to invest in energy-efficient infrastructure, renewable energy procurement, waste segregation technologies, and sustainable supply chain management. The immediate financial benefits of energy cost reduction and waste minimization further strengthen the business case, ensuring environmental solutions dominate the ESG component landscape throughout the forecast timeline.

The ESG Data & Analytics Services segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ESG Data & Analytics Services segment is predicted to witness the highest growth rate, fueled by healthcare organizations' urgent need to measure, benchmark, and improve their ESG performance accurately. Raw data from energy meters, procurement systems, and patient surveys must be transformed into actionable intelligence through sophisticated analytics, including carbon accounting, social impact scoring, and governance risk assessments. Machine learning models can identify hidden emission hotspots or predict supply chain vulnerabilities before they disrupt patient care. As reporting frameworks evolve and investor demands intensify, healthcare entities are increasingly outsourcing specialized analytics rather than building in-house capabilities, creating explosive demand for third-party data services that deliver audit-ready insights and competitive benchmarking.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, underpinned by stringent regulatory requirements, active shareholder advocacy, and the concentration of major healthcare systems. The U.S. Securities and Exchange Commission's proposed climate disclosure rules, combined with state-level healthcare sustainability mandates, create a compliance-driven market. Large integrated delivery networks and pharmaceutical corporations have dedicated ESG teams and substantial budgets, enabling early adoption of comprehensive solutions. Canadian healthcare sustainability initiatives further contribute. The presence of leading ESG software vendors and consulting firms headquartered in the region ensures continuous innovation and localized support, solidifying North America's dominant position throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR, driven by the European Union's pioneering Corporate Sustainability Reporting Directive and the European Green Deal's specific healthcare provisions. EU member states are implementing mandatory ESG disclosures for all large hospitals and health-related companies, with binding deadlines accelerating technology procurement. The region's strong public healthcare systems enable coordinated sustainability initiatives across national networks, creating economies of scale for ESG solution providers. Additionally, European healthcare procurement is increasingly weighting ESG criteria in tenders, forcing suppliers to demonstrate compliance. This regulatory leadership, combined with high environmental awareness among European citizens, positions Europe as the fastest-growing market for ESG in healthcare.

Key players in the market

Some of the key players in ESG in Healthcare Market include Johnson & Johnson, Pfizer Inc., Roche Holding AG, Novartis AG, Merck & Co., Inc., GlaxoSmithKline plc, Sanofi S.A., Abbott Laboratories, Becton, Dickinson and Company, Medtronic plc, Siemens Healthineers AG, Philips N.V., GE HealthCare Technologies Inc., UnitedHealth Group Incorporated, and CVS Health Corporation.

Key Developments:

In January 2026, Philips N.V. completed the acquisition of SpectraWAVE, integrating a "Circular Edition" portfolio approach to coronary interventional procedures to reduce medical waste.

In November 2025, Siemens Healthineers AG unveiled a new "Digital Twin" initiative designed to reduce the need for physical prototype testing, significantly lowering the carbon intensity of their R&D cycle.

In October 2025, Novartis AG confirmed a $23 billion investment in the U.S. manufacturing footprint over five years, focusing on resilient and localized supply chains to mitigate environmental risks from global logistics.

ESG Components Covered:

• Environmental Solutions
• Social Impact Solutions
• Governance & Compliance Solutions

Offerings Covered:

• ESG Software & Platforms
• Consulting & Advisory Services
• ESG Data & Analytics Services

Deployment Modes Covered:

• On-Premise
• Cloud-Based

End Users Covered:

• Hospitals & Healthcare Providers
• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Healthcare Payers & Insurance Providers
• Contract Research Organizations (CROs)

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global ESG in Healthcare Market, By ESG Component

• 5.1 Environmental Solutions
• 5.2 Social Impact Solutions
• 5.3 Governance & Compliance Solutions

6 Global ESG in Healthcare Market, By Offering

• 6.1 ESG Software & Platforms
• 6.2 Consulting & Advisory Services
• 6.3 ESG Data & Analytics Services

7 Global ESG in Healthcare Market, By Deployment Mode

• 7.1 On-Premise
• 7.2 Cloud-Based

8 Global ESG in Healthcare Market, By End User

• 8.1 Hospitals & Healthcare Providers
• 8.2 Pharmaceutical & Biotechnology Companies
• 8.3 Medical Device Companies
• 8.4 Healthcare Payers & Insurance Providers
• 8.5 Contract Research Organizations (CROs)

9 Global ESG in Healthcare Market, By Geography

• 9.1 North America
  • 9.1.1 United States
  • 9.1.2 Canada
  • 9.1.3 Mexico
• 9.2 Europe
  • 9.2.1 United Kingdom
  • 9.2.2 Germany
  • 9.2.3 France
  • 9.2.4 Italy
  • 9.2.5 Spain
  • 9.2.6 Netherlands
  • 9.2.7 Belgium
  • 9.2.8 Sweden
  • 9.2.9 Switzerland
  • 9.2.10 Poland
  • 9.2.11 Rest of Europe
• 9.3 Asia Pacific
  • 9.3.1 China
  • 9.3.2 Japan
  • 9.3.3 India
  • 9.3.4 South Korea
  • 9.3.5 Australia
  • 9.3.6 Indonesia
  • 9.3.7 Thailand
  • 9.3.8 Malaysia
  • 9.3.9 Singapore
  • 9.3.10 Vietnam
  • 9.3.11 Rest of Asia Pacific
• 9.4 South America
  • 9.4.1 Brazil
  • 9.4.2 Argentina
  • 9.4.3 Colombia
  • 9.4.4 Chile
  • 9.4.5 Peru
  • 9.4.6 Rest of South America
• 9.5 Rest of the World (RoW)
  • 9.5.1 Middle East
    • 9.5.1.1 Saudi Arabia
    • 9.5.1.2 United Arab Emirates
    • 9.5.1.3 Qatar
    • 9.5.1.4 Israel
    • 9.5.1.5 Rest of Middle East
  • 9.5.2 Africa
    • 9.5.2.1 South Africa
    • 9.5.2.2 Egypt
    • 9.5.2.3 Morocco
    • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

• 10.1 Industry Value Network and Supply Chain Assessment
• 10.2 White-Space and Opportunity Mapping
• 10.3 Product Evolution and Market Life Cycle Analysis
• 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

• 11.1 Mergers and Acquisitions
• 11.2 Partnerships, Alliances, and Joint Ventures
• 11.3 New Product Launches and Certifications
• 11.4 Capacity Expansion and Investments
• 11.5 Other Strategic Initiatives

12 Company Profiles

• 12.1 Johnson & Johnson
• 12.2 Pfizer Inc.
• 12.3 Roche Holding AG
• 12.4 Novartis AG
• 12.5 Merck & Co., Inc.
• 12.6 GlaxoSmithKline plc
• 12.7 Sanofi S.A.
• 12.8 Abbott Laboratories
• 12.9 Becton, Dickinson and Company
• 12.10 Medtronic plc
• 12.11 Siemens Healthineers AG
• 12.12 Philips N.V.
• 12.13 GE HealthCare Technologies Inc.
• 12.14 UnitedHealth Group Incorporated
• 12.15 CVS Health Corporation